Edition:
United States

Myriad Genetics Inc (MYGN.O)

MYGN.O on Nasdaq

32.07USD
28 Jul 2016
Change (% chg)

-- (--)
Prev Close
$32.07
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
897,713
52-wk High
$46.24
52-wk Low
$28.82

MYGN.O

Chart for MYGN.O

About

Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The Company is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. Myriad operates through two segments: diagnostics, which provides testing and collaborative development of testing that is designed to assess an... (more)

Overall

Beta: 0.57
Market Cap(Mil.): $2,254.49
Shares Outstanding(Mil.): 70.30
Dividend: --
Yield (%): --

Financials

  MYGN.O Industry Sector
P/E (TTM): 21.66 32.66 36.62
EPS (TTM): 1.48 -- --
ROI: 14.30 8.45 14.52
ROE: 15.04 12.67 15.68

BRIEF-Myriad's EndoPredict study meets primary endpoint

* Myriad announces positive results for an EndoPredict clinical study published in Journal of National Cancer Institute

Jul 11 2016

BRIEF-Myriad Genetics board approves additional $200 mln share repurchase program

* Myriad board approves $200 million increase in share repurchase program

Jun 07 2016

BRIEF-Myriad acquires Sividon Diagnostics for 35 mln euros

* Has acquired Sividon Diagnostics for eur 35 million upfront with potential for eur 15 million in additional performance-based milestones

May 31 2016

Myriad hit with complaint over access to genetic information

May 19 The American Civil Liberties Union on Thursday filed a complaint with the federal government accusing genetic testing company Myriad Genetics Inc of refusing to provide four patients with personal genetic information they requested, though the company has now provided it.

May 19 2016

Myriad hit with complaint over access to genetic information

The American Civil Liberties Union on Thursday filed a complaint with the federal government accusing genetic testing company Myriad Genetics Inc of refusing to provide four patients with personal genetic information they requested, though the company has now provided it.

May 19 2016

Myriad hit with complaint over access to genetic information

May 19 The American Civil Liberties Union on Thursday filed a complaint with the federal government accusing genetic testing company Myriad Genetics Inc of refusing to provide four patients with personal genetic information they requested, though the company has now provided it.

May 19 2016

BRIEF-Myriad Genetics issues statement on HIPAA complaint

* Complaint filed against co with department of health and human services on behalf of four individuals seeking their genetic testing results

May 19 2016

BRIEF-Myriad Genetics posts Q3 EPS of $0.44

* Q3 revenue $190.5 million versus I/B/E/S view $184.9 million

May 03 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : Wright Reports
$75.00
Provider : ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.